The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multiscale in silico knowledge-based model predicts tumor growth in advanced EGFR+ NSCLC patients on gefitinib.
 
Adèle L'Hostis
Research Funding - Janssen-Cilag (Inst)
 
Jean-Louis Palgen
Research Funding - Janssen-Cilag (Inst)
 
Nicoletta Ceres
Research Funding - Janssen-Cilag (Inst)
 
Angelique Perrillat-Mercerot
Research Funding - Janssen-Cilag (Inst)
 
Emmanuel Peyronnet
Research Funding - Janssen-Cilag (Inst)
 
Evgueni Jacob
Research Funding - Janssen-Cilag (Inst)
 
Riad Kahoul
Research Funding - Janssen-Cilag (Inst)
 
Matthieu Coudron
Research Funding - Janssen-Cilag (Inst)
 
Lucile Lefevre
Employment - Janssen-Cilag
 
Raphael Toueg
Employment - Janssen-Cilag
 
Andreea Todea
Employment - Janssen-Cilag
 
Marc Hommel
Research Funding - Janssen-Cilag (Inst)
 
Jean-Pierre Boissel
Research Funding - Janssen-Cilag (Inst)
 
Jim Bosley
Research Funding - Janssen-Cilag (Inst)
 
Michaël Duruisseaux
Consulting or Advisory Role - Abbvie; Amgen; Amgen; AstraZeneca; BMS; Boehringer Ingelheim; Janssen Oncology; MSD Oncology; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD
 
Claudio Monteiro
Research Funding - Janssen-Cilag (Inst)